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Aims: We investigated whether trans-fat supplemented over two generations of rats could alter neuronal
membranes and inﬂuence mania-like behaviors, as well as the effects of lithium (Li).
Main methods: Two generations of female rats were supplemented with soybean oil (SO-C, rich in n−6 fatty
acids — FA) or hydrogenated vegetable fat (HVF, rich in trans-fatty acids — TFA). Male rats born from the 1st
and 2nd generations were maintained in the same supplementation until adulthood, when they were exposed
to an amphetamine (AMPH)-induced model of mania and co-treated with Li or not.
Key ﬁndings: AMPH increased locomotion of both generations and this inﬂuence was higher in the HVF than in
the SO-C group. Conversely, AMPH increased long-termmemory in SO-C group of the 2nd generation. HVF sup-
plementation allowed hippocampal TFA incorporation in rats of both generations (0.1 and 0.2%, respectively).
Oxidative parameters indicated higher levels of protein carbonyl (PC) in the HVF group with no changes in cat-
alase (CAT) activity in the 1st generation. In the 2nd generation, AMPH increased PC levels of both experimental
groups, whereas CAT activity was lower per se in the HVF group only. The co-treatment with Li leveled out all
behavioral parameters, PC levels and CAT activity indicating a signiﬁcant neuroprotective role.
Signiﬁcance: These ﬁndings suggest that chronic HVF consumption allows a rising incorporation of TFA in the
brain, which may be reﬂected on the neuropsychiatric conditions related to mania, whereas the effects of Li
are not modiﬁed in the course of this harmful dietary habit.© 2015 Elsevier Inc. All rights reserved.1. Introduction
Fatty acids (FA) from dietary consumption inﬂuence the composi-
tion of brain membrane phospholipids [12]. In developmental periods,
this FA supply is particularly critical [31], since the type of FA incorpo-
rated into membranes modiﬁes their ﬂuidity, signal transduction and
transcription factors [1,53]. Clinical studies have shown that different
FA accumulated by the neonate must originate from maternal circula-
tion, milk and in a later stage from dietary sources. Thus, the deﬁciency
of essential lipids during developmental periods of life may have long-
term consequences for neural function [33–35]. Considering previous
studies of our group that have shown behavioral changes together
with changes in the FA proﬁle in different brain areas of rats [67–69],e Farmacologia, CCS Programa
ederal de Santa Maria, 97105-
r).a study involving cross-generational supplementation of FA becomes
relevant.
Interestingly, studies regarding western societies have shown a
growing incidence of neuropsychiatric diseases [32,36], raising con-
cerns about their etiology [58], including dietary habits. Indeed, studies
have shown increased consumption of processed foods rich in trans-
fatty acids (TFA), which is starting in early years [7,59,60]. In addition
to this, studies do not agree in ﬁndings regarding the adequate amount
of trans-FA in diets aswell as essential fatty acids [61]. Moreover, animal
studies in our group revealed the inﬂuence of TFA supplementation
on stress [52], drug preference [40] and the development of neuropsy-
chiatric disorders [65], including the mania aspect of bipolar disorder
(BD) [66–69].
While BD pathophysiology remains unclear, recent studies have
shown that after maniac or depressive episode patients presented
memory impairments [28,48], which may involve damages in the
hippocampal neurotransmission [3,49]. The neurotransmission imbal-
ance is a hypothesis that has gained force due to its relation to other
7V.T. Dias et al. / Life Sciences 132 (2015) 6–12pathways proposed to explain this illness, such as oxidative stress (OS),
inﬂammation (arachidonic acid cascade) and neurotrophic factors [9,
23,37].
The well-documented amphetamine (AMPH)-induced animal
model of mania [14,19,20] induces mania-like behaviors in animals,
which can be attenuated or reversed by classical mood-stabilizing
drugs such as lithium (Li). Such behaviors may be experimentally ob-
served by hyperactivity and sensitization, a characteristic that has
been reported as an augmentation in behavioral changes due to the re-
peated administration of psychostimulant drugs ([55], for a review),
which is also known as stereotyped behavior [20].
Considering that brain FA incorporation is a key process during de-
velopmental periods [50], we designed this study to assess the inﬂuence
of hippocampal FA incorporation over two generations of rats, whether
this incorporation may facilitate the development of an AMPH-induced
mania and has effects on Li activity according to behavioral and bio-
chemical parameters.
2. Materials and methods
2.1. Animals
Male and femaleWistar rats were used in the experimental proto-
cols. They were housed at four per cage with free access to food and
water in a room with controlled temperature (23 °C ± 1 °C), on a 12-
h light/12-h dark cycle with lights turned on at 7 a.m. throughout the
experimental period. All procedures with animals were approved by
the Research Ethics Committee of Universidade Federal de Santa Maria
(UFSM-24/2010), which is afﬁliated with the National Council for the
Control of Animal Experiments (CONCEA), following the international
norms of care and animal maintenance, and all efforts were made to
minimize the number of animals used and their suffering.
2.2. Experimental design
2.2.1. Protocol I— Effects of different supplementations on the ﬁrst genera-
tion of rats submitted to an AMPH-induced model of mania and co-treated
with lithium or not
Oneweekprior tomating, female adultWistar rats (n=12)were di-
vided into two experimental groups supplemented (3 g/kg; p.o.) [40,52,
67] with soybean oil (SO-C), an isocaloric control group due to its ade-
quate levels of polyunsaturated FA, n− 6/n− 3 ratio within acceptable
limits and broad global consumption [60,64,65,70,74]; or hydrogenated
vegetable fat (HVF), rich in TFA. The FA proﬁles of supplementations are
described by [67]. Female rats weremaintained under the same supple-
mentation throughout pregnancy and lactation. Fromweaning (postna-
tal day 21), one male pup from each litter was grouped and maintained
under the same oral treatment until 90 days of age (adulthood) when
they were submitted to an animal model of mania described as follows.
2.2.2. Protocol II — effects of different supplementations on the second
generation of rats submitted to an AMPH-induced model of mania and
co-treated with lithium or not
Animals were maintained under the same supplementation and
environmental conditions as in protocol I until the birth of the ﬁrst gen-
eration. One female pup of each litter wasmaintained on the same sup-
plementation until adulthood, when they were mated. Onemale pup of
each litter from those dams was grouped and maintained under the
same oral treatment until 90 days of age (adulthood) when they were
submitted to the animal model of mania.
2.3. Animal model of mania
At 90 days of age, half of each experimental group supplemented
with SO-C (n = 18) or HVF (n = 18) was submitted to an animal
model of mania. Male rats received a single daily injection of AMPH(4 mg/kg/ip; n = 12) or vehicle (saline; n = 6) for 14 days (adapted
from [19,20]). From the 8th to the last day (14th day) of AMPH admin-
istration, half of the animals in each group were co-treated with Li
(35 mg/kg/ip; n= 6) or vehicle (saline; n= 6) twice a day. The exper-
imental group Li alone was not included in this study since no effects of
this drug were observed on behaviors and on oxidative status in the
same animal model [19–21]. Twenty-four hours after the last injection,
the animals were submitted to behavioral assessments followed by eu-
thanasia for the biochemical assays.
2.4. Behavioral assessments
2.4.1. Open-ﬁeld test (OF)
Rats were placed individually in the center of an open-ﬁeld arena
(40 × 40 × 30 cm) enclosed by black matte walls and ﬂoor divided
into squares, as previously described by Kerr et al. [38]. For 5 min., the
number of crossings (horizontal squares crossed) was recorded asmea-
sures of spontaneous locomotor activity. Before the introduction of each
rat the open ﬁeld arena was cleaned with a 5% alcohol solution.
2.4.2. Novel object recognition task (NORT)
This test is related to the innate instinct of animals to explore novel-
ties as well as to recognize their environment [30]. The NORT was con-
ducted in the same open-ﬁeld arena 24 h after the locomotor status
observations. Recognition index was assessed as previously described
([15]; [75]. The arena ﬂoor was covered with sawdust (from bedding
material) during the recognition memory training and test trial. The
ﬁrst day consisted of the training trial in which rats were exposed to
two identical objects (A1 and A2, double Lego toys) positioned in two
adjacent corners, 9 cm from the walls, and were allowed to freely ex-
plore the objects for 10min. The long-termmemory test was performed
24 h after the training session and the animals were allowed 5 min to
freely explore the arena in the presence of two objects: a familiar object
A and a second novel object C, placed at the same locations as in the
training session. The objects had similar textures, colors, and sizes, but
with distinctive shapes and they were cleaned before the introduction
of each rat with a 5% alcohol solution. Every time the rats sniffed at, or
touched the object with the nose was deﬁned as exploration. A recogni-
tion index calculated for each animal was expressed by the ratio TN /
(TF + TN) (TF = time spent exploring the familiar object; TN = time
spent exploring the novel object).
2.5. Tissue preparations
After the end of behavioral assessments, rats of all experimental
groups were anesthetized (sodium pentobarbital, 50 mg/kg body
weight i.p.) and euthanized by cervical decapitation. Their brains were
immediately removed, maintained on ice, and cut coronally at the cau-
dal border of the olfactory tubercle for hippocampus removal [54]. One
half of each tissue was homogenized with 0.1 M Tris–HCl, pH 7.4 and
centrifuged at 3000 ×g (10 min), and the supernatants were used for
biochemical assays. To determine the FA proﬁle, another half of each
hippocampus from the vehicle-treated groups only (SO-C and HVF)
was used, as shown in Table 1.
2.6. Fatty acid proﬁle of the hippocampus
Fat was extracted from the hippocampus samples using chloroform
and methanol as described by [11]. In order to prevent lipid oxidation
during and after extraction, 0.02% butyl hydroxy toluene was added to
the chloroform used. FA composition was determined by gas chroma-
tography. Fat was saponiﬁed in a methanolic KOH solution and then es-
teriﬁed in amethanolic H2SO4 solution [29].Methylated fatty acidswere
analyzed using anAgilent Technologies gas chromatograph (HP 6890N)
equipped with a capillary column DB-23 (60 m × 0.25 mm × 0.25 μm)
and ﬂame ionization detector. The temperature of the injector port
Table 1
Hippocampal proﬁle of fatty acids of rats supplemented with different oil/fat in the ﬁrst
and second generation (% of total fatty acids identiﬁed).
First generation Second generation
Fatty acid SO-C HVF SO-C HVF
ΣSFA 42.8 ± 0.3 42.5 ± 0.0 40.4 ± 0.6⁎ 41.2 ± 0.4⁎
ΣMUFA 28.7 ± 0.6 27.9 ± 0.5 33.6 ± 0.3a⁎ 29.8 ± 0.6b
ΣPUFA 28.0 ± 0.1 27.1 ± 0.3 27.1 ± 0.5⁎ 26.8 ± 0.5
Σn−3 9.1 ± 0.0 8.9 ± 0.0 8.7 ± 0.0⁎ 8.9 ± 0.2
Σn−6 18.9 ± 0.1 18.9 ± 0.3 17.9 ± 0.0⁎ 17.2 ± 0.0⁎
ΣTFA n.d. 0.1 ± 0.0 n.d. 0.2 ± 0.0⁎
n− 6/n− 3 ratio 2.1 2.1 2.0 1.9⁎
Different lowercases indicate signiﬁcant difference between the SO-C and HVF groups in
the ﬁrst or second generation (P b 0.05). * indicates signiﬁcant difference the between
1st and 2nd generations in the same supplementation (P b 0.05). SFA: saturated fatty
acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; TFA:
trans-fatty acids.
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injection (1 μL, split ratio 50:1), the oven temperature was held at
160 °C for 1 min, then increased to 240 °C at 4 °C/min and held at this
temperature for 9 min. Standard FA methyl esters (37-component
FAME Mix, C 22:5n-3 and PUFA no. 2 from Sigma, Saint Louis, MO,
USA, and C 22:5n− 6 from NuChek Prep. Inc., Elysian, MN, USA) were
run under the same conditions and the subsequent retention times
were used to identify the FA. A percentage of the total FA content was
used to express FA composition.
2.7. Biochemical assays
2.7.1. Catalase (CAT) activity
The hippocampal enzyme activity was spectrophotometrically
quantiﬁed by the method of Aebi [2], which is based on monitoring
the disappearance of H2O2 at 240 nm. The enzymatic activity was
expressed in μmol H2O2/min/g tissue.
2.7.2. Protein carbonyl (PC) determination
The oxidative damage to hippocampal proteins was assessed with
the determination of carbonyl groups based on the reaction withFig. 1. Locomotor activity of the ﬁrst (A) and second (B) generation of rats supplementedwith S
or vehicle for 14 days. From the 8th to the last day (14th) of AMPH administration half of the an
Behavioral assessmentswere carried out 2 h after the last AMPH injection.Data are expressed as
Different lowercase letters indicate differences between supplementations in the same drug tre
tation (P b 0.05). # indicates signiﬁcant differences from AMPH-administered animals in the sdinitrophenylhydrazine (DNPH) as previously described [44], with
some modiﬁcations at 370 nm. The results were expressed in nmol/g
tissue.2.8. Statistical analysis
The FA contentmeasured in the hippocampus was analyzed by one-
way ANOVA followed by Duncan's test. Behavioral and biochemical as-
sessments were analyzed by two-way ANOVA followed by Duncan's
multiple range test when appropriate. A value of P b 0.05 was consid-
ered signiﬁcant for all comparisons made.3. Results
3.1. Locomotor activity of the ﬁrst and second generations of rats assessed
in open ﬁeld as shown in Fig. 1
Duncan's test showed no changes of supplementation per se in loco-
motor activity of animals of the 1st and 2nd generations (Fig. 1A, B).
AMPH administration increased crossing in SO-C and HVF groups of
both generations, although HVF presented a higher increase than that
in the SO-C group (Fig. 1A, B). The co-treatment with Li caused a reduc-
tion in locomotor activity in both groups of both generations (Fig. 1A, B).3.2. Long-term memory of the ﬁrst and second generations of rats assessed
in the novel object recognition test (NORT) as shown in Fig. 2
The post-hoc test showed that no inﬂuence of neither supplementa-
tion nor AMPH-administration was observed in the recognition index
among animals of the 1st generation (Fig. 2A), however, Li co-
treatment increased this index regardless of the supplementation. Re-
garding the animals of the 2nd generation (Fig. 2B), the post-hoc test
showed no differences in the supplementation per se, but AMPH admin-
istration increased the recognition index only in the SO-C group. While
the SO-C group co-treated with Li showed recognition index at baseline
level, Li could improve the recognition index in the HVF group, and was
higher than that quantiﬁed in the SO-C group.O-C or HVFwas assessed in an open ﬁeld test. Male ratswere treatedwith AMPH (4mg/kg)
imals in each group were co-treated with Li (35 mg/kg/ip) or vehicle (saline) twice a day.
mean±S.E.M. Abbreviations: SO-C: soybeanoil-control; HVF: hydrogenatedvegetable fat.
atment (P b 0.05). * indicates signiﬁcant differences from vehicle in the same supplemen-
ame supplementation (P b 0.05).
Fig. 2. Recognition index of theﬁrst (A) and second (B) generations of rats supplementedwith SO-C or HVFwas assessed on time spent on the novel object recognition test.Male ratswere
treated with AMPH (4mg/kg) or vehicle for 14 days. From the 8th to the last day (14th) of AMPH administration half of the animals in each group were co-treated with Li (35mg/kg/ip)
or vehicle (saline) twice a day. Long-termmemory retention test was performed 24 h after training. Data are expressed as mean± S.E.M. Abbreviations: SO-C: soybean oil-control; HVF:
hydrogenated vegetable fat. Different lowercase letters indicate differences between supplementations in the same drug treatment (P b 0.05). * indicates signiﬁcant differences from
vehicle in the same supplementation (P b 0.05). # indicates signiﬁcant differences from AMPH-administered animals in the same supplementation (P b 0.05).
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shown in Table 1
The HVF group showed a growing incorporation of TFA (0.1 and
0.2%, respectively) among animals of the 1st and 2nd generations exclu-
sively, whichwasnot observed in SO-C group. HVF supplementation de-
creased ΣMUFA by 11.3% in rats of the 2nd generation. Comparisons
between both generations revealed a decreased incorporation of ΣSFA
(5.6 and 3.0%) and Σn− 6 PUFA (5.3 and 9.0%) in the SO-C and HVF
groups, respectively. Additionally, SO-C supplementation during two
sequential generations allowed an increase of ΣMUFA (17%) as well
as a decrease in ΣPUFA (3.2%) and in Σn− 3 PUFA (4.4%), while HVF
supplementation was related to an increase in ΣTFA (100%) and aFig. 3. Inﬂuence of SO-C or HVF supplementation on hippocampal protein carbonyl levels of th
vehicle for 14 days. From the 8th to the last day (14th) of AMPHadministration half of the anima
are expressed as mean± S.E.M. Abbreviations: SO-C: soybean oil-control; HVF: hydrogenated v
the same drug treatment (P b 0.05). * indicates signiﬁcant differences from vehicle in the same
animals in the same supplementation (P b 0.05).decrease in the n− 6/n − 3 PUFA ratio (9.5%), compared to animals
of the 1st generation in the same supplementation.
3.4. The inﬂuence of different supplementations on protein carbonyl (PC)
levels in the hippocampus of the ﬁrst and second generations of rats as
shown in Fig. 3
Duncan's test showed that the different supplementation did not
change PC levels per se in both generations of rats (Fig. 3A and B).
Among animals of the 1st generation, AMPH administration increased
this oxidative parameter in the HVF group (Fig. 3A). In animals of the
2nd generation, AMPH increased PC levels in both SO-C andHVF groups,
and the values were similar (Fig. 3B). Interestingly, Li co-treatmente ﬁrst (A) and second (B) generations of rats. They were treated with AMPH (4 mg/kg) or
ls in each groupwere co-treatedwith Li (35mg/kg/ip) or vehicle (saline) twice a day. Data
egetable fat. Different lowercase letters indicate differences between supplementations in
supplementation (P b 0.05). # indicates signiﬁcant differences from AMPH-administered
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generations (Fig. 3A and B).
3.5. The inﬂuence of different supplementations on catalase (CAT) activity
in hippocampus of the ﬁrst and second generations of rats as shown in Fig. 4
Regarding the animals of the 1st generation, the different supple-
mentations exerted no effects per se in CAT activity. In addition, while
AMPH administration caused no signiﬁcant changes in CAT activity of
both supplemented groups, Li co-treatment decreased the activity of
this enzyme and the values were similar in both groups (Fig. 4A).
In the 2nd generation of rats, HVF supplementation was related to a
reduced CAT activity per se compared to the SO-C group. While AMPH
administration causedno signiﬁcant changes in this antioxidant defense
in both supplemented groups, Li co-treatment decreased CAT activity
in SO-C and no changes occurred in the HVF group, whose values
remained the same (Fig. 4B).
4. Discussion
The main purpose of this study was to assess whether the supple-
mentation with trans-fat during two sequential generations of rats
could alter the composition of hippocampal cell membranes, thus
affecting the susceptibility to develop AMPH-inducedmania-like symp-
toms, as well as the effects of administration of Li. Our current ﬁndings
showed that the type of fat or oil supplemented from mating to adult-
hood of two generations of rats could alter the FA proﬁle in the hippo-
campus of both generations, thus affecting behavioral parameters and
biochemical assessments related tomania developmentwith no chang-
es in the activity of Li, a classical mood stabilizer.
The experimental AMPH-induced sensitization has been used as a
well-documented animal model of mania ([19,20,66]). An interesting
fact in the current study was that HVF supplementation was related to
an increased hyperlocomotion induced by AMPH, which has been con-
sidered a mania-like symptom. However, Li treatment was able to con-
trol this behavioral parameter regardless of the supplementation and
the generation of animals.
Few studies investigate the effects of trans-FA consumption in early
years and its consequences in adult life regarding memory parameters
([13,24]). An interesting and innovative ﬁnding was observed in theFig. 4. Inﬂuence of SO-C or HVF supplementations on hippocampal catalase activity of theﬁrst (A
14 days. From the 8th to the last day (14th) of AMPH administration half of the animals in ea
expressed as mean ± S.E.M. Abbreviations: SO-C: soybean oil-control; HVF: hydrogenated ve
the same drug treatment (P b 0.05). * indicates signiﬁcant differences from vehicle in the same
animals in the same supplementation (P b 0.05).animals of the 2nd generation: when HVF supplementation hindered
the improvement of AMPH-induced memory, this improvement oc-
curred only in the SO-C group.
Amphetamines are known to enhance memory and cognitive func-
tions in animals and humans [71]. Also, memory consolidation can be
correlated with the hippocampal Arc/Arg3.1 protein synthesis [73]. Ad-
ditionally, some authors have inferred that amphetamine can improve
memory by activating the catecholaminergic system [47,72]. On the
other hand, AMPH administration was related to long-term memory
impairments, when rats were observed in the NORT paradigm [16],
although Bisagno et al. [10] reported that AMPH caused no impairments
on object recognition in rats. Based on these data, it is possible to infer
that ﬁndings are still poorly understood, since different treatments
can deﬁnitely inﬂuence this behavioral parameter. In the current
study, animals from the ﬁrst generation treated with DL-amphetamine
showed a tendency to enhance memory, regardless of the type of sup-
plemented fat.
Additionally, the inﬂuence of Li on memory is still controversial,
especially because little is known regarding the ﬁnal effects of lithium
on cognitive processes. In this sense, a study of memory reconsolidation
in rats showed no inﬂuence of Li, which was assessed in the NORT
paradigm [4]. Moreover, it was suggested that the improved cognitive
response related to Li administration might be better expressed under
challenging conditions to the central nervous system (CNS) [4]. Our
currentﬁndings agreewith these data, since Li treatmentwas able to in-
crease the recognition index in the HVF group of the second generation.
Interestingly, may we also suggest that the inﬂuence of Li on memory
parameters can be better evidenced in challenging situations, since
HVF-supplemented rats from the second generation showed double in-
corporation of TFA in hippocampal cell membranes, being a challenge to
the CNS.
Literature lacks studies that refer to the consumption of trans-FA in
early years and its consequences on behaviors related to neuropsychiat-
ric conditions, including BD. As the nervous system has a major role in
lipid concentration, the presence of non-essential fatty acids, such as
TFA becomes a challenge to the CNS, since their incorporation in the
cell membranes may be related to several impairments. Interestingly,
aged animals showed memory impairments after a prolonged supple-
mentation with trans-fat, whose behavioral impairments occurred to-
gether with TFA incorporation in brain cell membranes and damage in) and second (B) generation of rats. Theywere treatedwith AMPH(4mg/kg) or vehicle for
ch group were co-treated with Li (35 mg/kg/ip) or vehicle (saline) twice a day. Data are
getable fat. Different lowercase letters indicate differences between supplementations in
supplementation (P b 0.05). # indicates signiﬁcant differences from AMPH-administered
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deﬁciency was also related to memory impairments in animals, as
observed by different groups [5,17,26], thus reafﬁrming our current
hypothesis regarding the composition of brain cell membranes, which
is a pivotal factor to memory.
However, no study was developed showing sequential generations
of animals supplemented with trans-fat and its inﬂuence on mania-
like behavior and Li effects.
The exact mechanism related to these behavioral impairments ob-
served in animals supplemented with HVF is unknown although it is
possible to suggest the involvement of TFA incorporation in hippocam-
pal cell membranes. In fact, our ﬁndings showed the incorporation of
TFA in the hippocampus of the group supplemented with HVF in a
time-dependent manner, once rats from the 2nd generation showed
twice the incorporation in relation to the ones of the 1st generation.
We can reassume our hypothesis from previous and from this study
that prolonged consumption of trans-fat allowed a small but signiﬁcant
TFA incorporation in the hippocampus, indicating that this type of FA
may be modifying membrane ﬂuidity and neurotransmitter release,
thus impairing locomotion and blocking the increased memory perfor-
mance induced by AMPH. Of particular importance to our ﬁndings are
the signiﬁcant changes in the synaptic plasticity and ﬂuidity of mem-
branes due to TFA incorporation in the brain [42] as well as its affecting
dopamine (DA) neurotransmission [1], which have been reported.
It is well known that DA is a pivotal neurotransmitter in brain areas
related to behaviors such as locomotion and memory, especially in the
mesolimbic connections, which include the hippocampus [6,22,46].
Considering DA release, it is important to emphasize that in addition
to inhibiting the vesicular monoamine transporter (VMAT), AMPH
enhances DA releases from vesicular storage pools, along with the inhi-
bition of the activity of monoamine oxidase (MAO), thus reducing cyto-
solic DAmetabolism [63] and increasing the neurotransmitter level. The
excess of extracellular DA favors its autoxidation and consequently the
generation of reactive species (RS) [27], whose imbalance in the in-
creased production and decreased antioxidant defensesmay be hazard-
ous to neurons and tissues.
Considering that OS is one of the pathways implicated in the patho-
physiology of BD ([41,45,51,67,69,76]), and AMPH may increase the
general screening of oxidative status, this could result in further vulner-
ability to develop brain neurochemical alterations, and thatwas veriﬁed
in our study. AMPH administration increased the PC levels in HVF-
supplemented animals of both generations, and exerted no inﬂuences
per se. Similarly, the type of supplementation per se did not change the
hippocampal CAT activity in the animals of the 1st generation, but
HVF supplementation decreased the activity of this antioxidant in rats
of the 2nd generation. Again, our results revealed that Li co-treatment
could stabilize oxidative markers such as PC levels and CAT activity, re-
gardless of the supplementation or the generation of animals,
conﬁrming its fundamental role in mania-like disorders. Our study is
in accordance with [20], who suggested that Li exerts neuroprotective
effects on oxidative damages induced by AMPH, and also acts against in-
ﬂammatory processes [8,25,43]. In this sense, Li could act directly on the
AA cascade, decreasing the AA mobilization from brain membranes,
which is most likely related to the generation of less pro-
inﬂammatory metabolites. Therefore, Li may minimize this cascade,
exerting protection against the development of oxidative damage by
both pathways [9,39,56,57].
5. Conclusions
In summary, we observed that TFA from processed foods might be
signiﬁcantly incorporated into brain areas such as the hippocampus
through generations, thus facilitating the development of neuropsychi-
atric conditions, such as mania. As a consequence, AMPH effects were
altered increasing the susceptibility to hyperactivity and impairing
long-term memory. Besides behavioral changes, TFA incorporation inthe brain may interfere with the generation of more pro-inﬂammatory
metabolites affecting the oxidative pathway, compromising antioxidant
defenses and favoring the development of oxidative damage. In addi-
tion, our ﬁndings showed that hippocampal incorporation of TFA
exerted no inﬂuences on Li effects, which could balance both behavioral
and biochemical parameters regardless of the generation of animals.
Our initial hypothesis was partially conﬁrmed and the outcome sug-
gests that prolonged consumption of trans-fat in early years may in-
crease the vulnerability to the development of behavioral disturbances
related to neuropsychiatric disorders in adulthood.
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